| P50 | author | Héctor Peinado | Q42412761 |
| | Gema Moreno-Bueno | Q43675726 |
| | Giacomo Canesin | Q61469862 |
| | Celia López-Menéndez | Q96069622 |
| P2093 | author name string | Y Huang | |
| | A Cano | |
| | D Lyden | |
| | F Portillo | |
| | V Santos | |
| | K Csiszar | |
| | E P Cuevas | |
| P2860 | cites work | A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression | Q24314451 |
| | VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 |
| | Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche | Q24606366 |
| | Epithelial-mesenchymal transitions in development and disease | Q27860630 |
| | Lysyl oxidases: a novel multifunctional amine oxidase family | Q28201099 |
| | RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 |
| | Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 |
| | Elastic fiber homeostasis requires lysyl oxidase-like 1 protein | Q28240976 |
| | Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 |
| | The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase | Q28507440 |
| | Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice | Q28510969 |
| | Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 |
| | Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 |
| | Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs | Q33609142 |
| | Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas | Q34197948 |
| | LOXL2 in epithelial cell plasticity and tumor progression | Q34303455 |
| | E47 and Id1 interplay in epithelial-mesenchymal transition | Q34652699 |
| | Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation | Q35239845 |
| | Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis | Q36467995 |
| | The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells | Q36556697 |
| | LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis | Q36903532 |
| | The metastatic niche: adapting the foreign soil | Q36928869 |
| | Transcriptional regulation of cell polarity in EMT and cancer | Q37333606 |
| | LOXL2-mediated matrix remodeling in metastasis and mammary gland involution | Q37346579 |
| | The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. | Q37830915 |
| | The ins and outs of the epithelial to mesenchymal transition in health and disease | Q37899185 |
| | The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. | Q38011900 |
| | The rationale for targeting the LOX family in cancer | Q38027412 |
| | Regulatory networks defining EMT during cancer initiation and progression | Q38076317 |
| | A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. | Q38301815 |
| | Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. | Q39234744 |
| | Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. | Q39321728 |
| | Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition | Q39405423 |
| | Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment | Q39659310 |
| | Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway | Q39822163 |
| | Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas | Q39971722 |
| | Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo | Q40550757 |
| | LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. | Q41957208 |
| | Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. | Q42803679 |
| | Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation | Q46447933 |
| | Myeloid suppressor cells regulate the lung environment--letter. | Q50516834 |
| | The morphological and molecular features of the epithelial-to-mesenchymal transition | Q59123131 |
| | Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis | Q84595151 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 951-964 | |
| P577 | publication date | 2014-03-17 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization. | |
| P478 | volume | 34 | |